Alina Rayamajhi

Alina Rayamajhi practices at Abdallah Zaki, M.D., Inc. in Mission Hills, California.

Alina Rayamajhi's NPI, 1770254286, was assigned on September 23, 2021. Alina Rayamajhi holds California license 95014974.

Alina Rayamajhi's primary practice is Abdallah Zaki, M.D., Inc., at 11550 N Indian Hills Rd, Mission Hills, CA 91345 in Los Angeles County. The practice phone is (310) 440-3131.

Alina Rayamajhi's primary practice is Abdallah Zaki, M.D., Inc. in Mission Hills, California. The medical group on file is Kidney Consultants Medical Group. Dmand AI also links Alina Rayamajhi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alina Rayamajhi practices. Vendor and product names are available with a free account.

Nurse practitioner is Alina Rayamajhi's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Alina Rayamajhi is licensed in California.

CMS data shows 384 Medicare services from Alina Rayamajhi across 5 procedure codes in 2024, for 124 Medicare patients. Medicare paid $30,171 for them. Every service was in an office.

CMS counts 124 Medicare patients who saw Alina Rayamajhi in 2024. The largest group is 75 to 84, with 49 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 58% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alina Rayamajhi's median patient age at 69, with 50% women.

In 2024, Alina Rayamajhi wrote 3,171 Medicare Part D claims for 428 patients. 77% of them were for generic drugs. CMS names the drug for 2,926 of them, across 48 drugs with 11 or more claims each, at $591,518 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Alina Rayamajhi for performance year 2024, reported as part of a group. Alina Rayamajhi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 111 general payments to Alina Rayamajhi from 17 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $623.